Skip to content

Effectiveness of metacognitive training for schizophrenic patients: Randomized controlled trial

Effectiveness of metacognitive training for schizophrenic patients: Randomized controlled trial - Metacognitive training for schizophrenic patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000034106
Enrollment
46
Registered
2021-06-30
Start date
2018-09-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

During the hospital stay for a few months, metacognitive training (MCT) will be conducted twice a week, 16 times in total, in addition to usual occupational therapy. A usual occupational therapy will

Sponsors

Tikumaso Mental Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Person who is in hospital in psychiatric hospital. 2) Persons diagnosed with schizophrenia or schizophrenia affective disorder. 3) Person who prescribed occupational therapy from the attending physician. 4) After receiving sufficient explanation for the participation of this research, those who gained written consent based on the free will of the patient himself / herself.

Exclusion criteria

Exclusion criteria: 1) Person who is under 20 years old or over 65 years old. 2) Persons who have mergers such as intellectual disability, alcohol / drug dependence (substance abuse / dependence), dementia, epilepsy, head trauma, cerebrovascular disease etc. 3) Persons who are unstable in medical condition and have difficulty performing MCT or cognitive function test. 4) Persons who have not received occupational therapy. 5) Persons who can not obtain consent to participate in research. 6) Person who judged that the doctor or research director is ineligible.

Design outcomes

Primary

MeasureTime frame
Score change of The Brief Assessment of Cognition in Schizophrenia 3 months after treatment start or discharge

Secondary

MeasureTime frame
Score change of Positive and Negative Syndrome Scale 3 months after treatment start or discharge

Countries

Japan

Contacts

Public ContactMasayoshi Kobayashi

Shinshu University Graduate School of Health Science Division of Occupational Therapy

mkobaya@shinshu-u.ac.jp0263372403

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026